APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Oxycodone

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Oxycodone Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 174021490321 December 2025193 pages

Choose your research edition.

Industry ResearchOxycodone Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Oxycodone Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Oxycodone Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Oxycodone Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Oxycodone Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Oxycodone market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Oxycodone is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Oxycodone is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Oxycodone is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Oxycodone is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Oxycodone include Teva Pharmaceuticals, Sun Pharmaceutical (Chattem Chemicals), Sanofi, Johnson & Johnson, Mylan, Pfizer, Purdue Pharma, Mallinckrodt and Indivior, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Oxycodone market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Oxycodone and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Oxycodone sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Oxycodone market size, projected growth trends, production technologies, key applications, and end-use industries.

Oxycodone Segment by Company

Teva Pharmaceuticals

Sun Pharmaceutical (Chattem Chemicals)

Sanofi

Johnson & Johnson

Mylan

Pfizer

Purdue Pharma

Mallinckrodt

Indivior

Impax Laboratories

Hikma Pharmaceuticals (West-Ward Pharmaceuticals)

Endo International

Oxycodone Segment by Type

Long Acting Oxycodone

Short Acting Oxycodone

Oxycodone Segment by Application

Hospital Pharmacies

Retail Pharmacies

Others

Oxycodone Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Oxycodone market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Oxycodone and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Oxycodone.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Oxycodone market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Oxycodone manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Oxycodone in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Oxycodone in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Oxycodone Industry Trends Table 2. Oxycodone Industry Drivers Table 3. Oxycodone Industry Opportunities and Challenges Table 4. Oxycodone Industry Restraints Table 5. Global Oxycodone Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Oxycodone Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Oxycodone Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Oxycodone Sales Market Share by Manufacturers Table 9. Global Oxycodone Average Sales Price (US$/unit) of Manufacturers (2021-2026) Table 10. Global Oxycodone Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Oxycodone Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Oxycodone Manufacturers, Product Type & Application Table 13. Global Oxycodone Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Oxycodone by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Long Acting Oxycodone Table 17. Major Manufacturers of Short Acting Oxycodone Table 18. Global Oxycodone Sales by Type 2021 VS 2025 VS 2032 (k units) Table 19. Global Oxycodone Sales by Type (2021-2026) & (k units) Table 20. Global Oxycodone Sales by Type (2027-2032) & (k units) Table 21. Global Oxycodone Sales Market Share by Type (2021-2026) Table 22. Global Oxycodone Sales Market Share by Type (2027-2032) Table 23. Global Oxycodone Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 24. Global Oxycodone Revenue by Type (2021-2026) & (k units) Table 25. Global Oxycodone Revenue by Type (2027-2032) & (k units) Table 26. Global Oxycodone Revenue Market Share by Type (2021-2026) Table 27. Global Oxycodone Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Hospital Pharmacies Table 29. Major Manufacturers of Retail Pharmacies Table 30. Major Manufacturers of Others Table 31. Global Oxycodone Sales by Application 2021 VS 2025 VS 2032 (k units) Table 32. Global Oxycodone Sales by Application (2021-2026) & (k units) Table 33. Global Oxycodone Sales by Application (2027-2032) & (k units) Table 34. Global Oxycodone Sales Market Share by Application (2021-2026) Table 35. Global Oxycodone Sales Market Share by Application (2027-2032) Table 36. Global Oxycodone Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 37. Global Oxycodone Revenue by Application (2021-2026) & (k units) Table 38. Global Oxycodone Revenue by Application (2027-2032) & (k units) Table 39. Global Oxycodone Revenue Market Share by Application (2021-2026) Table 40. Global Oxycodone Revenue Market Share by Application (2027-2032) Table 41. Global Oxycodone Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 42. Global Oxycodone Sales by Region (2021-2026) & (k units) Table 43. Global Oxycodone Sales Market Share by Region (2021-2026) Table 44. Global Oxycodone Sales Forecasted by Region (2027-2032) & (k units) Table 45. Global Oxycodone Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Oxycodone Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 47. North America Oxycodone Sales by Country (2021-2026) & (k units) Table 48. North America Oxycodone Sales by Country (2027-2032) & (k units) Table 49. Europe Oxycodone Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 50. Europe Oxycodone Sales by Country (2021-2026) & (k units) Table 51. Europe Oxycodone Sales by Country (2027-2032) & (k units) Table 52. Asia Pacific Oxycodone Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 53. Asia Pacific Oxycodone Sales by Country (2021-2026) & (k units) Table 54. Asia Pacific Oxycodone Sales by Country (2027-2032) & (k units) Table 55. South America, Middle East and Africa Oxycodone Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 56. South America, Middle East and Africa Oxycodone Sales by Country (2021-2026) & (k units) Table 57. South America, Middle East and Africa Oxycodone Sales by Country (2027-2032) & (k units) Table 58. Global Oxycodone Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Oxycodone Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Oxycodone Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Oxycodone Revenue Market Share by Region (2021-2026) Table 62. Global Oxycodone Revenue Market Share by Region (2027-2032) Table 63. Teva Pharmaceuticals Company Information Table 64. Teva Pharmaceuticals Business Overview Table 65. Teva Pharmaceuticals Oxycodone Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Teva Pharmaceuticals Oxycodone Product Portfolio Table 67. Teva Pharmaceuticals Recent Development Table 68. Sun Pharmaceutical (Chattem Chemicals) Company Information Table 69. Sun Pharmaceutical (Chattem Chemicals) Business Overview Table 70. Sun Pharmaceutical (Chattem Chemicals) Oxycodone Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Sun Pharmaceutical (Chattem Chemicals) Oxycodone Product Portfolio Table 72. Sun Pharmaceutical (Chattem Chemicals) Recent Development Table 73. Sanofi Company Information Table 74. Sanofi Business Overview Table 75. Sanofi Oxycodone Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Sanofi Oxycodone Product Portfolio Table 77. Sanofi Recent Development Table 78. Johnson & Johnson Company Information Table 79. Johnson & Johnson Business Overview Table 80. Johnson & Johnson Oxycodone Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Johnson & Johnson Oxycodone Product Portfolio Table 82. Johnson & Johnson Recent Development Table 83. Mylan Company Information Table 84. Mylan Business Overview Table 85. Mylan Oxycodone Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Mylan Oxycodone Product Portfolio Table 87. Mylan Recent Development Table 88. Pfizer Company Information Table 89. Pfizer Business Overview Table 90. Pfizer Oxycodone Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Pfizer Oxycodone Product Portfolio Table 92. Pfizer Recent Development Table 93. Purdue Pharma Company Information Table 94. Purdue Pharma Business Overview Table 95. Purdue Pharma Oxycodone Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Purdue Pharma Oxycodone Product Portfolio Table 97. Purdue Pharma Recent Development Table 98. Mallinckrodt Company Information Table 99. Mallinckrodt Business Overview Table 100. Mallinckrodt Oxycodone Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Mallinckrodt Oxycodone Product Portfolio Table 102. Mallinckrodt Recent Development Table 103. Indivior Company Information Table 104. Indivior Business Overview Table 105. Indivior Oxycodone Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. Indivior Oxycodone Product Portfolio Table 107. Indivior Recent Development Table 108. Impax Laboratories Company Information Table 109. Impax Laboratories Business Overview Table 110. Impax Laboratories Oxycodone Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. Impax Laboratories Oxycodone Product Portfolio Table 112. Impax Laboratories Recent Development Table 113. Hikma Pharmaceuticals (West-Ward Pharmaceuticals) Company Information Table 114. Hikma Pharmaceuticals (West-Ward Pharmaceuticals) Business Overview Table 115. Hikma Pharmaceuticals (West-Ward Pharmaceuticals) Oxycodone Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 116. Hikma Pharmaceuticals (West-Ward Pharmaceuticals) Oxycodone Product Portfolio Table 117. Hikma Pharmaceuticals (West-Ward Pharmaceuticals) Recent Development Table 118. Endo International Company Information Table 119. Endo International Business Overview Table 120. Endo International Oxycodone Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 121. Endo International Oxycodone Product Portfolio Table 122. Endo International Recent Development Table 123. Key Raw Materials Table 124. Raw Materials Key Suppliers Table 125. Oxycodone Distributors List Table 126. Oxycodone Customers List Table 127. Research Programs/Design for This Report Table 128. Authors List of This Report Table 129. Secondary Sources Table 130. Primary Sources List of Figures Figure 1. Oxycodone Product Image Figure 2. Global Oxycodone Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Oxycodone Market Size (2021-2032) & (US$ Million) Figure 4. Global Oxycodone Sales (2021-2032) & (k units) Figure 5. Global Oxycodone Average Price (US$/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Oxycodone Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Long Acting Oxycodone Image Figure 9. Short Acting Oxycodone Image Figure 10. Global Oxycodone Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 11. Global Oxycodone Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Oxycodone Sales Market Share by Type (2021-2032) Figure 13. Global Oxycodone Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 14. Global Oxycodone Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Oxycodone Revenue Market Share by Type (2021-2032) Figure 16. Hospital Pharmacies Image Figure 17. Retail Pharmacies Image Figure 18. Others Image Figure 19. Global Oxycodone Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 20. Global Oxycodone Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Oxycodone Sales Market Share by Application (2021-2032) Figure 22. Global Oxycodone Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 23. Global Oxycodone Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Oxycodone Revenue Market Share by Application (2021-2032) Figure 25. North America Oxycodone Sales and Growth Rate (2021-2032) & (k units) Figure 26. North America Oxycodone Sales Market Share by Country (2021-2032) Figure 27. U.S. Oxycodone Sales and Growth Rate (2021-2032) & (k units) Figure 28. Canada Oxycodone Sales and Growth Rate (2021-2032) & (k units) Figure 29. Mexico Oxycodone Sales and Growth Rate (2021-2032) & (k units) Figure 30. Europe Oxycodone Sales and Growth Rate (2021-2032) & (k units) Figure 31. Europe Oxycodone Sales Market Share by Country (2021-2032) Figure 32. Germany Oxycodone Sales and Growth Rate (2021-2032) & (k units) Figure 33. France Oxycodone Sales and Growth Rate (2021-2032) & (k units) Figure 34. U.K. Oxycodone Sales and Growth Rate (2021-2032) & (k units) Figure 35. Italy Oxycodone Sales and Growth Rate (2021-2032) & (k units) Figure 36. Netherlands Oxycodone Sales and Growth Rate (2021-2032) & (k units) Figure 37. Asia Pacific Oxycodone Sales and Growth Rate (2021-2032) & (k units) Figure 38. Asia Pacific Oxycodone Sales Market Share by Country (2021-2032) Figure 39. China Oxycodone Sales and Growth Rate (2021-2032) & (k units) Figure 40. Japan Oxycodone Sales and Growth Rate (2021-2032) & (k units) Figure 41. South Korea Oxycodone Sales and Growth Rate (2021-2032) & (k units) Figure 42. Southeast Asia Oxycodone Sales and Growth Rate (2021-2032) & (k units) Figure 43. India Oxycodone Sales and Growth Rate (2021-2032) & (k units) Figure 44. Australia Oxycodone Sales and Growth Rate (2021-2032) & (k units) Figure 45. South America, Middle East and Africa Oxycodone Sales and Growth Rate (2021-2032) & (k units) Figure 46. South America, Middle East and Africa Oxycodone Sales Market Share by Country (2021-2032) Figure 47. Brazil Oxycodone Sales and Growth Rate (2021-2032) & (k units) Figure 48. South Africa Oxycodone Sales and Growth Rate (2021-2032) & (k units) Figure 49. Saudi Arabia Oxycodone Sales and Growth Rate (2021-2032) & (k units) Figure 50. Turkey Oxycodone Sales and Growth Rate (2021-2032) & (k units) Figure 51. Argentina Oxycodone Sales and Growth Rate (2021-2032) & (k units) Figure 52. UAE Oxycodone Sales and Growth Rate (2021-2032) & (k units) Figure 53. Egypt Oxycodone Sales and Growth Rate (2021-2032) & (k units) Figure 54. Chile Oxycodone Sales and Growth Rate (2021-2032) & (k units) Figure 55. Global Oxycodone Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Oxycodone Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Oxycodone Revenue (2021-2032) & (US$ Million) Figure 58. North America Oxycodone Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Oxycodone Revenue (2021-2032) & (US$ Million) Figure 60. Europe Oxycodone Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Oxycodone Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Oxycodone Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Oxycodone Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Oxycodone Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Oxycodone Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Oxycodone Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Long Acting Oxycodone
  • Short Acting Oxycodone
Applications
  • Hospital Pharmacies
  • Retail Pharmacies
  • Others
Companies covered
  • Teva Pharmaceuticals
  • Sun Pharmaceutical (Chattem Chemicals)
  • Sanofi
  • Johnson & Johnson
  • Mylan
  • Pfizer
  • Purdue Pharma
  • Mallinckrodt
  • Indivior
  • Impax Laboratories
  • Hikma Pharmaceuticals (West-Ward Pharmaceuticals)
  • Endo International

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Oxycodone Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Oxycodone Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Oxycodone Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Oxycodone Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Oxycodone Market Dynamics
  1. 2.1 Oxycodone Industry Trends
  2. 2.2 Oxycodone Industry Drivers
  3. 2.3 Oxycodone Industry Opportunities and Challenges
  4. 2.4 Oxycodone Industry Restraints
3 Oxycodone Market by Manufacturers
  1. 3.1 Global Oxycodone Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Oxycodone Sales by Manufacturers (2021-2026)
  3. 3.3 Global Oxycodone Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Oxycodone Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Oxycodone Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Oxycodone Manufacturers, Product Type & Application
  7. 3.7 Global Oxycodone Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Oxycodone Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Oxycodone Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Oxycodone Tier 1, Tier 2, and Tier 3
4 Oxycodone Market by Type
  1. 4.1 Oxycodone Type Introduction
  2. 4.1.1 Long Acting Oxycodone
  3. 4.1.2 Short Acting Oxycodone
  4. 4.2 Global Oxycodone Sales by Type
  5. 4.2.1 Global Oxycodone Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Oxycodone Sales by Type (2021-2032)
  7. 4.2.3 Global Oxycodone Sales Market Share by Type (2021-2032)
  8. 4.3 Global Oxycodone Revenue by Type
  9. 4.3.1 Global Oxycodone Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Oxycodone Revenue by Type (2021-2032)
  11. 4.3.3 Global Oxycodone Revenue Market Share by Type (2021-2032)
5 Oxycodone Market by Application
  1. 5.1 Oxycodone Application Introduction
  2. 5.1.1 Hospital Pharmacies
  3. 5.1.2 Retail Pharmacies
  4. 5.1.3 Others
  5. 5.2 Global Oxycodone Sales by Application
  6. 5.2.1 Global Oxycodone Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Oxycodone Sales by Application (2021-2032)
  8. 5.2.3 Global Oxycodone Sales Market Share by Application (2021-2032)
  9. 5.3 Global Oxycodone Revenue by Application
  10. 5.3.1 Global Oxycodone Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Oxycodone Revenue by Application (2021-2032)
  12. 5.3.3 Global Oxycodone Revenue Market Share by Application (2021-2032)
6 Global Oxycodone Sales by Region
  1. 6.1 Global Oxycodone Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Oxycodone Sales by Region (2021-2032)
  3. 6.2.1 Global Oxycodone Sales by Region (2021-2026)
  4. 6.2.2 Global Oxycodone Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Oxycodone Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Oxycodone Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Oxycodone Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Oxycodone Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Oxycodone Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Oxycodone Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Oxycodone Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Oxycodone Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Oxycodone Revenue by Region
  1. 7.1 Global Oxycodone Revenue by Region
  2. 7.1.1 Global Oxycodone Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Oxycodone Revenue by Region (2021-2026)
  4. 7.1.3 Global Oxycodone Revenue by Region (2027-2032)
  5. 7.1.4 Global Oxycodone Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Oxycodone Revenue (2021-2032)
  8. 7.2.2 North America Oxycodone Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Oxycodone Revenue (2021-2032)
  11. 7.3.2 Europe Oxycodone Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Oxycodone Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Oxycodone Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Oxycodone Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Oxycodone Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Teva Pharmaceuticals
  2. 8.1.1 Teva Pharmaceuticals Company Information
  3. 8.1.2 Teva Pharmaceuticals Business Overview
  4. 8.1.3 Teva Pharmaceuticals Oxycodone Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Teva Pharmaceuticals Oxycodone Product Portfolio
  6. 8.1.5 Teva Pharmaceuticals Recent Developments
  7. 8.2 Sun Pharmaceutical (Chattem Chemicals)
  8. 8.2.1 Sun Pharmaceutical (Chattem Chemicals) Company Information
  9. 8.2.2 Sun Pharmaceutical (Chattem Chemicals) Business Overview
  10. 8.2.3 Sun Pharmaceutical (Chattem Chemicals) Oxycodone Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Sun Pharmaceutical (Chattem Chemicals) Oxycodone Product Portfolio
  12. 8.2.5 Sun Pharmaceutical (Chattem Chemicals) Recent Developments
  13. 8.3 Sanofi
  14. 8.3.1 Sanofi Company Information
  15. 8.3.2 Sanofi Business Overview
  16. 8.3.3 Sanofi Oxycodone Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Sanofi Oxycodone Product Portfolio
  18. 8.3.5 Sanofi Recent Developments
  19. 8.4 Johnson & Johnson
  20. 8.4.1 Johnson & Johnson Company Information
  21. 8.4.2 Johnson & Johnson Business Overview
  22. 8.4.3 Johnson & Johnson Oxycodone Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Johnson & Johnson Oxycodone Product Portfolio
  24. 8.4.5 Johnson & Johnson Recent Developments
  25. 8.5 Mylan
  26. 8.5.1 Mylan Company Information
  27. 8.5.2 Mylan Business Overview
  28. 8.5.3 Mylan Oxycodone Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Mylan Oxycodone Product Portfolio
  30. 8.5.5 Mylan Recent Developments
  31. 8.6 Pfizer
  32. 8.6.1 Pfizer Company Information
  33. 8.6.2 Pfizer Business Overview
  34. 8.6.3 Pfizer Oxycodone Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Pfizer Oxycodone Product Portfolio
  36. 8.6.5 Pfizer Recent Developments
  37. 8.7 Purdue Pharma
  38. 8.7.1 Purdue Pharma Company Information
  39. 8.7.2 Purdue Pharma Business Overview
  40. 8.7.3 Purdue Pharma Oxycodone Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Purdue Pharma Oxycodone Product Portfolio
  42. 8.7.5 Purdue Pharma Recent Developments
  43. 8.8 Mallinckrodt
  44. 8.8.1 Mallinckrodt Company Information
  45. 8.8.2 Mallinckrodt Business Overview
  46. 8.8.3 Mallinckrodt Oxycodone Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Mallinckrodt Oxycodone Product Portfolio
  48. 8.8.5 Mallinckrodt Recent Developments
  49. 8.9 Indivior
  50. 8.9.1 Indivior Company Information
  51. 8.9.2 Indivior Business Overview
  52. 8.9.3 Indivior Oxycodone Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Indivior Oxycodone Product Portfolio
  54. 8.9.5 Indivior Recent Developments
  55. 8.10 Impax Laboratories
  56. 8.10.1 Impax Laboratories Company Information
  57. 8.10.2 Impax Laboratories Business Overview
  58. 8.10.3 Impax Laboratories Oxycodone Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Impax Laboratories Oxycodone Product Portfolio
  60. 8.10.5 Impax Laboratories Recent Developments
  61. 8.11 Hikma Pharmaceuticals (West-Ward Pharmaceuticals)
  62. 8.11.1 Hikma Pharmaceuticals (West-Ward Pharmaceuticals) Company Information
  63. 8.11.2 Hikma Pharmaceuticals (West-Ward Pharmaceuticals) Business Overview
  64. 8.11.3 Hikma Pharmaceuticals (West-Ward Pharmaceuticals) Oxycodone Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Hikma Pharmaceuticals (West-Ward Pharmaceuticals) Oxycodone Product Portfolio
  66. 8.11.5 Hikma Pharmaceuticals (West-Ward Pharmaceuticals) Recent Developments
  67. 8.12 Endo International
  68. 8.12.1 Endo International Company Information
  69. 8.12.2 Endo International Business Overview
  70. 8.12.3 Endo International Oxycodone Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Endo International Oxycodone Product Portfolio
  72. 8.12.5 Endo International Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Oxycodone Value Chain Analysis
  2. 9.1.1 Oxycodone Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Oxycodone Production Mode & Process
  6. 9.2 Oxycodone Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Oxycodone Distributors
  9. 9.2.3 Oxycodone Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst